Muraglitazar, a dual (α/γ) PPAR activator: A randomized, double-blind, placebo-controlled, 24-week monotherapy trial in adult patients with type 2 diabetes
Titel:
Muraglitazar, a dual (α/γ) PPAR activator: A randomized, double-blind, placebo-controlled, 24-week monotherapy trial in adult patients with type 2 diabetes
Auteur:
Buse, John B. Rubin, Cindy J. Frederich, Robert Viraswami-Appanna, Kalyanee Lin, Kwo-Chuan Montoro, Rafael Shockey, Gerald Davidson, Jaime A.